Cargando…
RS1 gene is a novel prognostic biomarker for lung adenocarcinoma
BACKGROUND: Although it has a poor prognosis, patients with lung adenocarcinoma (LUAD) have a relatively higher 5‐year survival period. Thus, it is necessary to identify effective prognostic markers to evaluate the effect of early treatment. RS1 gene encodes retinoschisin, a key protein in congenita...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200886/ https://www.ncbi.nlm.nih.gov/pubmed/35569920 http://dx.doi.org/10.1111/1759-7714.14471 |